Suprema, a company known for its AI-enhanced security product range, has announced that its BioStation 3 device is on track to set a new annual global sales record by the end of this year.
This development underscores growing international demand for facial authentication solutions and marks the highest annual sales record for Suprema’s biometric devices to date.
Growth in the Global Security Market
The sales surge for BioStation 3 reflects steady growth across several key regions, rather than an isolated increase in one area. The device has experienced over 30 percent sales growth year-over-year in significant markets such as the United Kingdom, the Americas, Japan, and the Middle East.
Additionally, large-scale implementations of 600 to over 1,000 units at high-security locations, including public institutions and financial entities, have fortified its market position.
Key Competitive Factors of BioStation 3
BioStation 3’s competitive edge in the market can be attributed to three primary factors
BioStation 3’s competitive edge in the market can be attributed to three primary factors. Firstly, its AI-powered facial authentication system ensures high accuracy and reliability, offering secure, seamless access in various environments. Secondly, the device is designed to enhance user experience by adapting to real-world operating conditions, merging convenience with security.
Lastly, BioStation 3 boasts robust data protection features, adhering to GDPR regulations and successfully passing the iBeta ISO/IEC 30107-3 PAD test for facial spoofing. It utilizes advanced encryption and Suprema’s Template on Mobile (ToM) authentication, empowering users to manage their own data.
Trust and Adoption in Conservative Markets
These security features have fostered trust in markets like the United States and the United Kingdom, where the adoption of facial authentication technologies faces rigorous regulatory and conservational scrutiny.
BioStation 3 is increasingly being implemented in prominent projects, paving the way for wider integration across various sectors in the following year.
Recognition at the 2025 Readers' Choice Awards
BioStation 3 has also earned recognition from security industry experts, having been awarded the Best Product title
BioStation 3 has also earned recognition from security industry experts, having been awarded the Best Product title in the Biometrics category at the 2025 Readers’ Choice Awards hosted by Security Buyer magazine.
This award honors innovation and potential market impact, as voted on by security professionals.
Addressing Security Industry Challenges
“The record-breaking sales performance and global award recognition of BioStation 3 demonstrate how AI-powered facial authentication technology is rapidly establishing its presence in the global market. It is particularly meaningful that major international clients with stringent security requirements have recognized the accuracy and reliability of BioStation 3 and adopted it in real-world projects,” remarked Hanchul Kim, CEO of Suprema Inc.
He added that Suprema remains committed to addressing challenges in the security sector through ongoing innovation that bolsters both security and user convenience.
Discover how AI, biometrics, and analytics are transforming casino security
Suprema, a pioneer of AI-powered security solutions, announced that BioStation 3 is expected to set a new annual global sales record by the end of this year.
This represents the highest annual sales record for Suprema’s biometric devices and highlights the accelerating global demand for facial authentication solutions.
Global security market
Importantly, this growth reflects balanced momentum across major regions rather than a temporary spike in a single market. BioStation 3 has achieved more than 30 percent year-over-year sales growth in key markets, including the United Kingdom, the Americas, Japan, and the Middle East.
In addition, deployments ranging from 600 to over 1,000 units at high-security sites such as public institutions, financial organizations, and large-scale residential complexes have further strengthened its position in the global security market.
BioStation 3’s three key factors
Three key factors underpin BioStation 3’s recognized competitiveness worldwide. First, its AI-powered facial authentication delivers high accuracy and stable performance, enabling administrators and end users to experience secure, seamless access authentication in real-world environments. Second, its user experience is optimized for actual operating conditions, enhancing both convenience and security even under diverse environments and complex security requirements.
Finally, these strengths are supported by BioStation 3’s robust data protection capabilities. BioStation 3 complies with GDPR, one of the world’s most stringent data protection regulations, and has successfully passed iBeta’s ISO/IEC 30107-3 Presentation Attack Detection (PAD) test for facial spoofing. It also incorporates advanced data protection and encryption technologies, along with Suprema’s innovative Template on Mobile (ToM) authentication method, which allows users to directly manage their own personal data.
Building on these strong data protection and privacy capabilities, BioStation 3 has earned a high level of trust in markets such as the United States and the United Kingdom, where adoption of facial authentication has traditionally been more conservative and regulatory requirements are stringent, and it is now being actively deployed in major projects. As a result, broader adoption across a wider range of industry sectors is expected next year.
Biometrics category at the 2025 Readers’ Choice Awards
BioStation 3’s value has been demonstrated not only through its sales performance but also through recognition from industry experts. It received the Best Product award in the Biometrics category at the 2025 Readers’ Choice Awards, hosted by the global security publication Security Buyer magazine.
This prestigious award is organized by Security Buyer, a leading media outlet covering global security industry trends and emerging technologies, and is presented to products whose innovation and market potential have been validated through voting by security professionals.
Emerging challenges in the security industry
“The record-breaking sales performance and global award recognition of BioStation 3 demonstrate how AI-powered facial authentication technology is rapidly establishing its presence in the global market. It is particularly meaningful that major international clients with stringent security requirements have recognized the accuracy and reliability of BioStation 3 and adopted it in real-world projects,” said Hanchul Kim, CEO of Suprema Inc.
“Suprema will continue to address emerging challenges in the security industry and lead global standards through continuous innovation that enhances both security and convenience.”
